Central serous chorioretinopathy associated with administration of sympathomimetic agents

John C. Michael, John Pak, Jose S Pulido, Guillermo De Venecia

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.

Original languageEnglish (US)
Pages (from-to)182-185
Number of pages4
JournalAmerican Journal of Ophthalmology
Volume136
Issue number1
DOIs
StatePublished - Jul 1 2003
Externally publishedYes

Fingerprint

Central Serous Chorioretinopathy
Sympathomimetics
Oxymetazoline
Pseudoephedrine
N-Methyl-3,4-methylenedioxyamphetamine
Fluorescein
Eating

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Central serous chorioretinopathy associated with administration of sympathomimetic agents. / Michael, John C.; Pak, John; Pulido, Jose S; De Venecia, Guillermo.

In: American Journal of Ophthalmology, Vol. 136, No. 1, 01.07.2003, p. 182-185.

Research output: Contribution to journalArticle

Michael, John C. ; Pak, John ; Pulido, Jose S ; De Venecia, Guillermo. / Central serous chorioretinopathy associated with administration of sympathomimetic agents. In: American Journal of Ophthalmology. 2003 ; Vol. 136, No. 1. pp. 182-185.
@article{353fea0761044bffa1a9d2d6887dec98,
title = "Central serous chorioretinopathy associated with administration of sympathomimetic agents",
abstract = "PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.",
author = "Michael, {John C.} and John Pak and Pulido, {Jose S} and {De Venecia}, Guillermo",
year = "2003",
month = "7",
day = "1",
doi = "10.1016/S0002-9394(03)00076-X",
language = "English (US)",
volume = "136",
pages = "182--185",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Central serous chorioretinopathy associated with administration of sympathomimetic agents

AU - Michael, John C.

AU - Pak, John

AU - Pulido, Jose S

AU - De Venecia, Guillermo

PY - 2003/7/1

Y1 - 2003/7/1

N2 - PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.

AB - PURPOSE: To report central serous chorioretinopathy associated with excessive use of compounds with sympathomimetic activity. DESIGN: Observational case series. METHODS: Four patients presented with clinical and fluorescein angiographic evidence of central serous chorioretinopathy. All patients expressed a concomitant psychogenic stress and high-dose ingestion of pseudoephedrine, oxymetazoline, or 3,4-methylenedioxymethamphetamine, all of which possess sympathomimetic properties. RESULTS: In all cases, resolution of central serous chorioretinopathy coincided with cessation of the medication. CONCLUSIONS: Patients afflicted with central serous chorioretinopathy should be notified about its possible association with sympathomimetic medications.

UR - http://www.scopus.com/inward/record.url?scp=0038692189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038692189&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(03)00076-X

DO - 10.1016/S0002-9394(03)00076-X

M3 - Article

C2 - 12834690

AN - SCOPUS:0038692189

VL - 136

SP - 182

EP - 185

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 1

ER -